Not applicableActive Not RecruitingNCT01582204
What this trial is testing
Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
Who this might be right for
Renal Cancer
Memorial Sloan Kettering Cancer Center 17